Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Submitted by admin on October 25, 2023 - 9:51am
Source: 
Motley Fool
News Tags: 
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Headline: 
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
snippet: 
  • Novo Nordisk has reported strong revenue and profit growth over the past five years.
  • The company recently upgraded its guidance for 2023.
  • In the long run, the company can get even bigger as it looks to become a large player in a huge market for GLP-1 drugs.

Do Not Allow Advertisers to Use My Personal information